相关实验视频
Updated: Jun 29, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.6K
严重的COVID-19与心力衰竭的临床表现:单中心回顾性研究
Xinling Liu1, Tingting Liu1, Rong Wan1
1Department of Quality Management, The 904th Hospital of Joint Logistic Support Force (Wuxi Taihu Hospital), Wuxi, Jiangsu 214044, P.R. China.
Experimental and therapeutic medicine
|April 9, 2024
概括
患有严重心力衰竭 (HF) 和冠状病毒疾病-19 (COVID-19) 的患者经历了更糟糕的结果,包括更高的死亡率和更长的住院时间. 这突显了在流行病期间改善护理策略的关键需求.
科学领域:
- 心脏病学 心脏病学
- 传染性疾病 传染性疾病
- 公共卫生 公共卫生
背景情况:
- 在全球范围内,COVID-19大流行严重影响了公共卫生干预措施.
- 严重心力衰竭 (HF) 带来了独特的挑战,特别是当加上像COVID-19这样的严重感染时.
研究的目的:
- 评估严重冠状病毒病-19 (COVID-19) 患者严重心力衰竭 (HF) 的临床特征和结果.
- 为了比较COVID-19和没有COVID-19的严重HF患者之间的结果.
主要方法:
- 一个单一中心的观测研究于2022年11月至2023年4月在中国无锡进行.
- 包括210名被诊断患有严重高血压的患者,其中128人同时患有COVID-19.
- 分析医疗记录,包括实验室值,住院时间,死亡率和成本.
主要成果:
- 两组之间没有发现基线特征的显著差异.
- 结合COVID-19的HF显示30天死亡率显著增加 (28.91%对14.63%).
- 患有HF和COVID-19的患者经历了更长的住院时间,更高的住院费用,以及肺炎,呼吸衰竭和妄想等并发症的增加率.
结论:
- 心力衰竭与COVID-19相结合,导致治疗结果和预后明显恶化.
- 了解这些影响对于在流行病期间改进高风患者的护理至关重要.
- 加强对未来流行病的准备,需要特别关注脆弱人群,如那些患有严重高频率的人群.
更多相关视频
相关概念视频
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Acute Respiratory Failure-II
218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184
COPD: Pathogenesis and Clinical Features
267
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
267

